Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: A randomised cross-over trial.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
03 Feb 2022
Historique:
received: 23 08 2021
accepted: 13 01 2022
entrez: 4 2 2022
pubmed: 5 2 2022
medline: 5 2 2022
Statut: aheadofprint

Résumé

To determine the comparative bronchodilator, systemic beta This open-label, cross-over, single-centre, controlled trial, randomised adults with asthma to different orders of two treatment regimens: salbutamol 200 µg The comparative bronchodilator responses of repeated administration of salbutamol 200 µg dose

Identifiants

pubmed: 35115339
pii: 13993003.02309-2021
doi: 10.1183/13993003.02309-2021
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©The authors 2022. For reproduction rights and permissions contact permissions@ersnet.org.

Auteurs

Nethmi Kearns (N)

Medical Research Institute of New Zealand, Wellington, New Zealand nethmi.kearns@mrinz.ac.nz.

Pepa Bruce (P)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Mathew Williams (M)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Marjan Doppen (M)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Melissa Black (M)

Medical Research Institute of New Zealand, Wellington, New Zealand.

Mark Weatherall (M)

Department of Medicine, University of Otago, Wellington, New Zealand.

Richard Beasley (R)

Medical Research Institute of New Zealand, Wellington, New Zealand.
School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand.
Department of Respiratory Medicine, Capital and Coast District Health Board, Wellington, New Zealand.

Classifications MeSH